In this issue:
Usual diets of adults with IBD
Continuing 5-ASA after anti-TNF/immunomodulator initiation in IBD
Point-of-care GI ultrasound for IBD decision-making and management
First and second switches to infliximab biosimilars
Dietary intake pattern is associated with IBD flare
Dual biologic/small molecule therapy in refractory paediatric IBD
Predictors of ustekinumab failure in CD after dose intensification
Subclinical pulmonary involvement in active IBD responds to biologic therapy
Depression in individuals who go on to develop IBD
Calprotectin normalisation <1 year of CD diagnosis reduces progression risk
Please login below to download this issue (PDF)